» Articles » PMID: 26579454

Pharmacokinetic Analysis and Tissue Distribution of Vam3 in the Rat by a Validated LC-MS/MS Method

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2015 Nov 19
PMID 26579454
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Vam3 is a potential pharmacologically active ingredient isolated from Vitis amurensis Rupr. A rapid, simple and sensitive method to determine Vam3 levels in rat plasma and tissue was developed based on LC-MS/MS. Vam3 and an internal standard (IS) were chromatographed on a C18 short column with acetonitrile-0.1% formic acid in water by gradient elution. MS detection was performed by electrospray ionization in negative ion multiple reaction-monitoring modes. This method monitored the transitions m/z 451.0→345.0 and m/z 301.0→164.0 for Vam3 and IS, respectively. The calibration curve was linear over a concentration range of 1.64-1000 ng/mL. The inter-day and intra-day variabilities in precision was less than 12.8%, while the inter-day and intra-day accuracies ranged from -10.60% to 9.08% in plasma and tissue homogenates. This method was applied to investigate the pharmacokinetics and tissue distribution of Vam3 in rats. The results indicated that Vam3 had poor absorption into systemic circulation and extensive tissue distribution after oral administration, and the absolute bioavailability was low (0.79%). Vam3 had a relatively long terminal elimination half-life in lung, and the highest concentration was found in small intestinal tissue. The developed method and the pharmacokinetic data can provide a basis for further studies on the bioactivity of Vam3.

Citing Articles

Influence of the estrus cycle of the mouse on the disposition of SHetA2 after vaginal administration.

Mahjabeen S, Hatipoglu M, Benbrook D, Kosanke S, Garcia-Contreras D, Garcia-Contreras L Eur J Pharm Biopharm. 2018; 130:272-280.

PMID: 30064701 PMC: 6092953. DOI: 10.1016/j.ejpb.2018.07.004.


Pharmacokinetics, bioavailability, metabolism and excretion of δ-viniferin in rats.

Mao P, Lei Y, Zhang T, Ma C, Jin B, Li T Acta Pharm Sin B. 2016; 6(3):243-52.

PMID: 27175336 PMC: 4857012. DOI: 10.1016/j.apsb.2016.03.008.

References
1.
Ha D, Kim H, Thuong P, Minh Ngoc T, Lee I, Hung N . Antioxidant and lipoxygenase inhibitory activity of oligostilbenes from the leaf and stem of Vitis amurensis. J Ethnopharmacol. 2009; 125(2):304-9. DOI: 10.1016/j.jep.2009.06.019. View

2.
Shi J, Yin N, Xuan L, Yao C, Meng A, Hou Q . Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy. Acta Pharmacol Sin. 2012; 33(7):888-96. PMC: 4011152. DOI: 10.1038/aps.2012.73. View

3.
Rahman I, Adcock I . Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006; 28(1):219-42. DOI: 10.1183/09031936.06.00053805. View

4.
Kasiotis K, Pratsinis H, Kletsas D, Haroutounian S . Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol. 2013; 61:112-20. DOI: 10.1016/j.fct.2013.03.038. View

5.
Shen T, Wang X, Lou H . Natural stilbenes: an overview. Nat Prod Rep. 2009; 26(7):916-35. DOI: 10.1039/b905960a. View